Skip to main content
. 2021 Aug 27;8:740461. doi: 10.3389/fmed.2021.740461

Table 3.

Demographic, clinical, and laboratory values in 238,321 hemodialysis patients according to dialyzer type in the Japanese classification.

I II III IV V P value
n (%) 2,255 (1.0) 2,322 (1.0) 5,730 (2.4) 177,251 (74.3) 50,763 (21.3)
Age (years) 74.8 ± 10.8 74.2 ± 11.4 69.2 ± 12.4 67.2 ± 12.3 62.6 ± 12.4 <0.0001
Sex (% female) 53.3 49.6 41.4 39.0 31.0 <0.0001
Dialysis duration (years) 3 [1–6] 3 [1–7] 5 [2–9] 6 [3–10] 7 [4–13] <0.0001
Presence of DM (%) 50.9 47.8 46.2 44.5 39.4 <0.0001
Comorbid CVD (%) 35.1 32.3 27.4 27.6 23.0 <0.0001
 Coronary artery disease 10.6 9.6 8.9 8.4 7.3
 Ischemic stroke 23.1 19.8 16.3 16.3 12.8
 Hemorrhagic stroke 6.3 7.0 5.0 5.4 4.5
 Limb amputation 3.6 3.9 3.4 3.2 2.9
BMI (kg/m2) 19.9 ± 3.6 20.1 ± 3.5 20.9 ± 3.5 21.2 ± 3.6 21.8 ± 3.8 <0.0001
Hemoglobin (g/dL) 10.0 ± 1.4 10.1 ± 1.4 10.3 ± 1.3 10.5 ± 1.3 10.6 ± 1.2 <0.0001
Serum albumin (g/dL) 3.4 ± 0.5 3.4 ± 0.5 3.6 ± 0.4 3.7 ± 0.4 3.7 ± 0.4 <0.0001
Calcium (mg/dL) 8.6 ± 0.9 8.7 ± 0.9 8.8 ± 0.8 8.9 ± 0.8 9.0 ± 0.8 <0.0001
Phosphate (mg/dL) 4.9 ± 1.6 4.9 ± 1.5 5.2 ± 1.5 5.2 ± 1.4 5.4 ± 1.5 <0.0001
Intact PTH (pg/mL) 114 [55–197] 108 [57–191] 119 [59–206] 114 [57–195] 122 [64–204] <0.0001
β2-microglobulin, (mg/L) 29.0 ± 11.3 28.2 ± 10.1 27.7 ± 7.7 26.6 ± 7.0 26.9 ± 6.8 <0.0001
C-reactive protein (mg/dL) 0.2 [0.1–0.8] 0.2 [0.1–0.7] 0.1 [0.1–0.5] 0.1 [0.1–0.4] 0.1 [0.1–0.3] <0.0001
Kt/V 1.27 ± 0.29 1.30 ± 0.29 1.40 ± 0.28 1.43 ± 0.28 1.45 ± 0.28 <0.0001
nPCR (g/kg/day) 0.79 ± 0.20 0.79 ± 0.18 0.84 ± 0.19 0.86 ± 0.18 0.89 ± 0.18 <0.0001
%CGR (%) 71.6 ± 29.8 72.4 ± 29.7 87.3 ± 30.0 91.9 ± 28.8 99.8 ± 26.2 <0.0001
Mortality rate (/person-years) 0.22 0.20 0.11 0.09 0.06 <0.0001

%CGR, percent creatinine generation rate; CVD, cardiovascular disease; DM, diabetes mellitus; nPCR, normalized protein catabolic rate; PTH, parathyroid hormone.